Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (241-250 of 393) with videos related to

Pageof 40
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment ValuesFakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti, et al.
Analytical Chemistry|July 21, 2015
Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysisMarco Guerrini, Timothy R Rudd, Lucio Mauri, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic low-molecular-weight heparins: some practical considerationsJawed Fareed, Wendy L Leong, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Arterial-renal Syndrome in Patients with ESRD, a New Disease ParadigmJake Goldstein, Robert S Dieter, Vinod Bansal, et al.
Hepato-Gastroenterology|September 21, 2002
Hemostatic modulation with the liver dialysis device in humans with advanced liver diseaseMagdalene M George, David H Van Thiel, George Tarasuk, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2020
Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD StudyGrigoris T Gerotziafas, Theodoros Zografos, Ioannis Pantos, et al.
Journal of Vascular Surgery|December 13, 2016
Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activatorDaniel Dansdill, Pegge M Halandras, Joshua Beverly, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2012
Comparative studies on branded enoxaparin and a US generic version of enoxaparinJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 13, 2023
Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine HeparinGuy Olson, Walter Jeske, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2018
Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney DiseaseJustin Lee, Jack Bontekoe, Brandon Trac, et al.
Pageof 40

Showing results (241-250 of 393) with videos related to

Sort By:
Pageof 40
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 13, 2019
Reversal of Factor Xa Inhibitors by Andexanet Alfa May Increase Thrombogenesis Compared to Pretreatment ValuesFakiha Siddiqui, Alfonso Tafur, Lorenzo Storino Ramacciotti, et al.
Analytical Chemistry|July 21, 2015
Differentiation of generic enoxaparins marketed in the United States by employing NMR and multivariate analysisMarco Guerrini, Timothy R Rudd, Lucio Mauri, et al.
Seminars in Thrombosis and Hemostasis|January 5, 2005
Generic low-molecular-weight heparins: some practical considerationsJawed Fareed, Wendy L Leong, Debra A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 12, 2022
Arterial-renal Syndrome in Patients with ESRD, a New Disease ParadigmJake Goldstein, Robert S Dieter, Vinod Bansal, et al.
Hepato-Gastroenterology|September 21, 2002
Hemostatic modulation with the liver dialysis device in humans with advanced liver diseaseMagdalene M George, David H Van Thiel, George Tarasuk, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2020
Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD StudyGrigoris T Gerotziafas, Theodoros Zografos, Ioannis Pantos, et al.
Journal of Vascular Surgery|December 13, 2016
Synthetic, organic compound vepoloxamer (P-188) potentiates tissue plasminogen activatorDaniel Dansdill, Pegge M Halandras, Joshua Beverly, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2012
Comparative studies on branded enoxaparin and a US generic version of enoxaparinJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 13, 2023
Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine HeparinGuy Olson, Walter Jeske, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 24, 2018
Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney DiseaseJustin Lee, Jack Bontekoe, Brandon Trac, et al.
Pageof 40